Medical Devices Startups

Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets. The company also maintains an oncology pipeline with partnered and in-house programs for unmet medical needs.

1 investor

ReelLife Conversations is an app that uses family photographs to prompt meaningful conversations for people with dementia and their caregivers, grounded in reminiscence therapy. The platform helps connect people, places, and objects in photos to generate conversation starters, supporting emotional wellbeing and natural interactions without tests or pressure.

1 investor

Rees Scientific manufactures centralized monitoring systems for facilities, including hardware platforms and cloud-based solutions for tracking critical equipment and environmental conditions. The company serves industrial and facility management operations requiring compliance, scalability, and remote monitoring capabilities.

1 investor

Reference Medicine supplies biological specimens to researchers and diagnostics developers working on cancer diagnostic tools. The company sources materials to support biotech and life sciences research.

1 investor

Refocus Group develops the VisAbility Micro Insert System, a medical device for treating presbyopia that operates outside the visual axis to reduce dependence on reading glasses.

1 investor

Regenosca develops TissueSpan, an absorbable mesh implant that prompts the body to attract and organize its own cells for soft tissue regeneration, reinforcing or replacing damaged tissue. Its initial target application is urethral stricture repair, with potential use across a range of regenerative surgical interventions.

1 investor

Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]

1 investor

Reglagene develops a brain-penetrant oral drug therapy designed to treat primary tumors and brain metastases in patients with cancer. The company focuses on CNS oncology, targeting a mechanism validated in solid tumors but previously unexploited for brain-penetrant therapies.

1 investor

Reichert manufactures diagnostic devices for eye care, including tonometers, refraction systems, and acuity charts used by ophthalmologists, optometrists, and veterinary professionals. The company is a business unit of AMETEK and operates globally from Buffalo, New York.

1 investor

Rein Medical provides integrated operating room solutions including wall-mounted monitors, workstations, and SMART OR software designed to manage multiple video signal sources efficiently. The company specializes in video transmission technology and hardware systems for hospital operating theaters.

1 investor

Reinsberg Group is a European MedTech holding that owns medical manufacturers (including Medifa, PROTEC, Rein Medical, Brandon Medical, Tedisel Medical, FAMED Zywiec and ALVO Medical) producing hospital equipment such as surgical tables, operating lights, X-ray systems, ICU units, modular hospital rooms and medical IT/video management. It sells full-scale hospital and surgical environment solutions to healthcare facilities worldwide across five continents.

1 investor

REJOIN is a medical device manufacturer specializing in minimally invasive orthopedic and biological products for joint and sports medicine surgery. The company serves orthopedic surgeons and hospitals globally with arthroscopic equipment, surgical instruments, and biological integration solutions.

1 investor

REKAH Pharmaceutical Industries is an Israeli manufacturer of generic pharmaceuticals, cosmetics, vitamins, nutritional supplements, and medical devices, with subsidiaries handling production, R&D, marketing, sales, distribution, and international expansion.

1 investor

Relatable Healthcare develops Product Relationship Management software for medical device and supply companies, helping them manage product data, competitive intelligence, and customer relationships to drive revenue growth. The platform serves MedTech organizations seeking to optimize commercialization operations and reduce costs.

1 investor

Relevium Medical is a biopharmaceutical company developing long-lasting treatments for chronic pain conditions, particularly osteoarthritis. The company focuses on therapeutic hydrogels and drug discovery for patients with debilitating pain.

1 investor

RELISTOR is a prescription medication containing methylnaltrexone bromide that treats opioid-induced constipation in adults with chronic pain or advanced illness. The drug is available in tablet and injection forms and is marketed for patients requiring pain management with opioids.

1 investor

Relu offers AI-powered segmentation and registration software for CBCT scans, digital impressions, and facial scans used in dental and oral surgery workflows. The company provides APIs and SDKs that enable dental software developers to automate implant planning, orthodontics, and surgical applications.

1 investor

Relu is an AI company that automates dental design and planning workflows, offering software to segment teeth from CBCT scans and generate AI-powered designs for dental clinics and labs. Its products are integrated into medical devices and carry CE marking and FDA 510(k) clearance, with markets across Europe, North America, and East Asia.

1 investor

REMware offers DreamClear, a sleep apnea management system that guides patients from home-test ordering through treatment and integrates into value-based care organizations. It serves ACOs, HMOs, TPAs and payors with EMR integration, a proprietary home-test kit, compliance monitoring, and end-to-end claim handling to detect and treat sleep disorders and reduce chronic-disease complications.

1 investor

Renalis develops prescription digital therapeutics (PDTs), software applications that deliver evidence-based therapeutic interventions to patients under a clinician's care to prevent or treat medical disorders. The products are developed like pharmaceuticals, undergoing clinical trials and FDA clearance, and are available only by clinician prescription.

1 investor

ReNerve develops nerve repair products, including cuffs, grafts, and bionic nerve structures, to treat transected nerves and improve patient outcomes. The company operates research laboratories in Melbourne, Australia, and collaborates with researchers at the CSIRO / Monash University biomaterials precinct.

1 investor

Renovion develops ARINA-1, a next-generation mucolytic therapy delivered as a sterile buffered ascorbic acid and glutathione solution to the lungs. The therapy targets chronic inflammatory airway diseases affecting over 170 million patients globally, including non-cystic fibrosis bronchiectasis, chronic bronchitis, COPD, and asthma.

1 investor

RenovoRx develops targeted oncology therapies and commercializes the RenovoCath, an FDA-cleared drug-delivery device for intra-arterial chemotherapy administration in cancer treatment. The company is conducting Phase III clinical trials of its proprietary TAMP therapy platform for treating locally advanced pancreatic cancer with improved safety and efficacy compared to systemic chemotherapy.

1 investor

Renovo Solutions operates a Life Sciences business line providing services and solutions to pharmaceutical, biotech, medical device, and laboratory services companies.

1 investor